Related references
Note: Only part of the references are listed.Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody
Jo Anne Welsch et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis
Vincent E. Weynants et al.
INFECTION AND IMMUNITY (2007)
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitildis group B in England
Caroline Trotter et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins
Katrin Haupt et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: Implications for the development of a multicomponent group B vaccine
Peter T. Beernink et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870
Oliver Koeberling et al.
VACCINE (2007)
Borrelia burgdorferi complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes is expressed in humans and induces antibody responses restricted to nondenatured structural determinants
Evelyn Rossmann et al.
INFECTION AND IMMUNITY (2006)
Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients
Elene Haralambous et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Selective binding of Borrelia burgdorferi OspE paralogs to factor H and serum proteins from diverse animals:: Possible expansion of the role of OspE in Lyme disease pathogenesis
KM Hovis et al.
INFECTION AND IMMUNITY (2006)
Complement escape of human pathogenic bacteria by acquisition of complement regulators
P Kraiczy et al.
MOLECULAR IMMUNOLOGY (2006)
Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870
VC Hou et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis
M Toropainen et al.
INFECTION AND IMMUNITY (2005)
CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcription
R Ieva et al.
JOURNAL OF BACTERIOLOGY (2005)
The region comprising amino acids 100 to 255 of Neisseria meningitidis, lipoprotein GNA 1870 elicits bactericidal antibodies
MM Giuliani et al.
INFECTION AND IMMUNITY (2005)
Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis
T Sprong et al.
BLOOD (2003)
Reverse vaccinology and genomics
R Rappuoli et al.
SCIENCE (2003)
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine
AE Platonov et al.
VACCINE (2003)
Comprehensive analysis of the factor H binding capabilities of Borrelia species associated with Lyme disease:: Delineation of two distinct classes of factor H binding proteins
JV McDowell et al.
INFECTION AND IMMUNITY (2003)
Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients
AE Platonov et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2003)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine
SL Harris et al.
INFECTION AND IMMUNITY (2003)
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains
GR Moe et al.
INFECTION AND IMMUNITY (2002)
The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15
TG Duthy et al.
INFECTION AND IMMUNITY (2002)
Streptococcal β protein has separate binding sites for human factor H and IgA-Fc
T Areschoug et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Meningococcal disease in Dallas County, Texas: results of a six-year population-based study
P Pastor et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
H Tettelin et al.
SCIENCE (2000)
Share Paper
